Ontology highlight
ABSTRACT: Background
Out-of-pocket medication costs for patients who have heart failure with reduced ejection fraction may be an important part of shared decision-making, but cost has generally been excluded from clinical discussions. This study reports patients' perspectives on a decision aid for sacubitril/valsartan that explicitly addresses out-of-pocket costs.Methods
Structured, in-depth interviews were conducted with 20 patients with heart failure with reduced ejection fraction from 2 medical centers to elicit their views on a publicly available decision aid for sacubitril/valsartan that explicitly incorporates considerations related to out-of-pocket costs. Qualitative descriptive analysis was conducted.Results
Key themes identified were general enthusiasm for decision a
SUBMITTER: Dickert NW
PROVIDER: S-EPMC7738420 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature